NIH RFP

Requests for Applications

  • Dementia Care and Caregiver Support Interventions (R01 – Clinical Trial Required)
    (RFA-AG-18-030)
    National Institute on Aging
    Application Receipt Date(s): April 10, 2018, by 5:00 PM

  • Consortia for HIV/AIDS Vaccine Development (CHAVD) (UM1 Clinical Trial Not Allowed)
    (RFA-AI-18-001)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): June 28, 2018 , by 5:00 PM

  • NIAMS Skin Biology and Diseases Resource-based Centers (P30 Clinical Trail Not Allowed)
    (RFA-AR-19-001)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Application Receipt Date(s): June 11, 2018 , by 5:00 PM

  • NIAMS Musculoskeletal Biology and Medicine Resource-based Centers (P30 Clinical Trial Not Allowed)
    (RFA-AR-19-002)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Application Receipt Date(s): June 11, 2018, by 5:00 PM

  • Limited Competition for the Continuation of the Clinical Centers for The Environmental Determinants of Diabetes in the Young (TEDDY) Study (U01 Clinical Trial Not Allowed )
    (RFA-DK-17-511)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): April 26, 2018 , by 5:00 PM

  • Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Clinical Trial Not Allowed)
    (RFA-ES-18-004)
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): June 20, 2018, by 5:00 PM

  • Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed)
    (RFA-MD-18-006)
    Application Receipt Date(s): April 16, 2018, by 5:00 PM

  • NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)
    (RFA-MH-19-130)
    National Institute of Mental Health
    Application Receipt Date(s): June 20, 2018 and June 20, 2019, by 5:00 PM

  • Structural Biology of Alzheimer’s Disease Related Dementias (ADRDs) Proteinopathies (U01 Clinical Trial Not Allowed)
    (RFA-NS-18-015)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): April 30, 2018, by 5:00 PM

  • Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)
    (RFA-NS-18-024)
    National Institute of Neurological Disorders and Stroke
    National Institute on Aging
    Application Receipt Date(s): April 17, 2018, by 5:00 PM

Program Announcements

  • Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
    (PA-18-629)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)
    (PA-18-631)
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.

  • NIDA Small Research Grant Program (R03 Clinical Trial Required)
    (PA-18-634)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM

  • NEI Academic Research Enhancement Award for Mechanistic and Minimal Risk Human Subjects’ Research (R15 Clinical Trial Optional)
    (PA-18-635)
    National Eye Institute
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM

  • NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional)
    (PA-18-642)
    National Institute of Mental Health
    Application Receipt/Submission Date(s): NIMH accepts and reviews applications on a continuous basis until April 1 of each fiscal year. Applications received after April 1 will be considered for funding in the next fiscal year. Earlier submission is strongly encouraged. Applications for FY 18 funds should be submitted no later than April 1, 2018. Applications for FY 19 funds should be submitted no later than April 1, 2019. Applications for FY 20 funds should be submitted no later than April 1, 2020 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp Clinical Trial Optional)
    (PA-18-647)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): July 1, 2018; March 1, 2019, July 1, 2019, March 1 2020, July 1, 2020, March 1, 2021 by 5:00 PM local time of applicant organization.

  • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
    (PA-18-648)
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
    (PAR-18-628)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.

  • Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
    (PAR-18-630)
    National Institute of Allergy and Infectious Diseases
    National Institute on Aging
    National Institute of General Medical Sciences
    Application Receipt/Submission Date(s): April 10, 2018; December 7, 2018; March 7, 2019; December 7, 2019 , by 5:00 PM

  • NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
    (PAR-18-632)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019; September 13, 2019; January 13, 2020; May 13, 2020; September 14, 2020; January 13, 2021, by 5:00 PM

  • NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
    (PAR-18-633)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019; September 13, 2019; January 13, 2020; May 13, 2020; September 14, 2020; January 13, 2021), by 5:00 PM

  • Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 – Clinical Trial Optional)
    (PAR-18-638)
    National Cancer Institute
    Application Receipt/Submission Date(s): June 13, 2018; October 11, 2018, June 13, 2019, by 5:00 PM

  • Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 – Clinical Trial Optional)
    (PAR-18-639)
    National Cancer Institute
    Application Receipt/Submission Date(s): June 13, 2018; October 11, 2018, June 13, 2019, by 5:00 PM

  • Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)
    (PAR-18-640)
    National Cancer Institute
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt/Submission Date(s): May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM

  • Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)
    (PAR-18-641)
    National Cancer Institute
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt/Submission Date(s): May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM

  • NHLBI Clinical Ancillary Studies (R01 – Clinical Trial Optional)
    (PAR-18-643)
    National Heart, Lung, and Blood Institute
    Application Receipt/Submission Date(s): April 30, 2018, August 24, 2018, December 18, 2018, April 30, 2019, August 24, 2019, December 18, 2019, April 30, 2020, August 24, 2020, and December 18, 2020, by 5:00 PM

  • Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 – Clinical Trial Optional)
    (PAR-18-644)
    National Institute on Aging
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional)
    (PAR-18-645)
    National Institute on Aging
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Opportunities for Collaborative Research at the NIH Clinical Center (U01 – Clinical Trial Optional)
    (PAR-18-646)
    Application Receipt/Submission Date(s): April 11, 2018, by 5:00 PM

  • Human-Animal Interaction (HAI) Research (R03 – Clinical Trial Optional)
    (PAR-18-649)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt/Submission Date(s): March 30, 2018, March 30, 2019, by 5:00 PM

  • Human-Animal Interaction (HAI) Research (R21 – Clinical Trial Optional)
    (PAR-18-650)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt/Submission Date(s): March 30, 2018, March 30, 2019, by 5:00 PM